JP2023054375A5 - - Google Patents

Download PDF

Info

Publication number
JP2023054375A5
JP2023054375A5 JP2023028902A JP2023028902A JP2023054375A5 JP 2023054375 A5 JP2023054375 A5 JP 2023054375A5 JP 2023028902 A JP2023028902 A JP 2023028902A JP 2023028902 A JP2023028902 A JP 2023028902A JP 2023054375 A5 JP2023054375 A5 JP 2023054375A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
antimicrobial
antibacterial
composition according
aqueous carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023028902A
Other languages
English (en)
Japanese (ja)
Other versions
JP7656643B2 (ja
JP2023054375A (ja
Filing date
Publication date
Priority claimed from JP2019554855A external-priority patent/JP2020513016A/ja
Application filed filed Critical
Publication of JP2023054375A publication Critical patent/JP2023054375A/ja
Publication of JP2023054375A5 publication Critical patent/JP2023054375A5/ja
Priority to JP2025049135A priority Critical patent/JP2025090864A/ja
Application granted granted Critical
Publication of JP7656643B2 publication Critical patent/JP7656643B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023028902A 2017-04-06 2023-02-27 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 Active JP7656643B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025049135A JP2025090864A (ja) 2017-04-06 2025-03-24 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762482630P 2017-04-06 2017-04-06
US62/482,630 2017-04-06
JP2019554855A JP2020513016A (ja) 2017-04-06 2018-04-05 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
PCT/US2018/026322 WO2018187617A1 (en) 2017-04-06 2018-04-05 Compositions and uses of locally applied antimicrobials with enhanced performance and safety

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019554855A Division JP2020513016A (ja) 2017-04-06 2018-04-05 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025049135A Division JP2025090864A (ja) 2017-04-06 2025-03-24 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Publications (3)

Publication Number Publication Date
JP2023054375A JP2023054375A (ja) 2023-04-13
JP2023054375A5 true JP2023054375A5 (cg-RX-API-DMAC7.html) 2023-11-15
JP7656643B2 JP7656643B2 (ja) 2025-04-03

Family

ID=63712780

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019554855A Pending JP2020513016A (ja) 2017-04-06 2018-04-05 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
JP2023028902A Active JP7656643B2 (ja) 2017-04-06 2023-02-27 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
JP2025049135A Pending JP2025090864A (ja) 2017-04-06 2025-03-24 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019554855A Pending JP2020513016A (ja) 2017-04-06 2018-04-05 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025049135A Pending JP2025090864A (ja) 2017-04-06 2025-03-24 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Country Status (11)

Country Link
US (3) US11285189B2 (cg-RX-API-DMAC7.html)
EP (1) EP3606543A4 (cg-RX-API-DMAC7.html)
JP (3) JP2020513016A (cg-RX-API-DMAC7.html)
KR (2) KR20200018400A (cg-RX-API-DMAC7.html)
CN (1) CN110740744A (cg-RX-API-DMAC7.html)
AU (2) AU2018249552A1 (cg-RX-API-DMAC7.html)
BR (1) BR112019020781A2 (cg-RX-API-DMAC7.html)
CA (1) CA3058901C (cg-RX-API-DMAC7.html)
MX (2) MX393548B (cg-RX-API-DMAC7.html)
SG (1) SG11201909016TA (cg-RX-API-DMAC7.html)
WO (1) WO2018187617A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX344635B (es) 2012-03-23 2017-01-04 Amicrobe Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con el tejido.
CN110740744A (zh) 2017-04-06 2020-01-31 艾麦克罗比公司 性能和安全性增强的局部施用的抗微生物剂的组合物和应用
JP2023501385A (ja) * 2019-11-08 2023-01-18 ユニバーシティ オブ ピッツバーグ - オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 抗微生物ペプチドを含む組成物
CN115397454A (zh) * 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌
WO2021207164A1 (en) * 2020-04-08 2021-10-14 Amicrobe, Inc. Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections
US12371463B2 (en) 2021-04-20 2025-07-29 University of Pittsburgh—of the Commonwealth System of Higher Education Methods and compositions for treatment of antibiotic-resistant bacterial infections
WO2026060306A1 (en) * 2024-09-13 2026-03-19 Macro Biologics, Inc. Compositions and uses of locally applied synthetic cationic and hydrophobic amino acid block copolymers, for prevention and treatment of bacterial and fungal infections

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6632922B1 (en) 1998-03-19 2003-10-14 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6680365B1 (en) 1998-03-19 2004-01-20 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
WO2000050006A2 (en) 1999-02-26 2000-08-31 Chiron Corporation Microemulsions with adsorbed macromoelecules and microparticles
US20030138453A1 (en) 2000-09-28 2003-07-24 O'hagan Derek Microparticles for delivery of heterologous nucleic acids
US6835536B2 (en) * 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
WO2003020797A1 (en) 2001-08-30 2003-03-13 The Regents Of The University Of California Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
JP2003171463A (ja) 2001-12-06 2003-06-20 Chisso Corp ポリリジン及びその製造法
CA2443472A1 (en) 2002-02-07 2003-08-14 Ophtecs Corporation Liquid formulation for contact lenses
DK1585548T3 (en) 2002-12-09 2018-09-03 Abraxis Bioscience Llc COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
WO2005005436A2 (en) 2003-07-11 2005-01-20 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
WO2005018701A1 (en) 2003-08-25 2005-03-03 Kane Biotech Inc. Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
CA2550872C (en) 2003-12-30 2016-05-03 Stig Bengmark Surface protection of exposed biological tissues
EP1722819B1 (en) 2004-03-12 2007-12-26 Intercell AG Method for solubilising peptide mixtures
DK1927597T3 (en) 2004-08-18 2017-02-13 Novabiotics Ltd ANTIBACTERIAL PEPTIDES
KR20080023218A (ko) 2005-06-06 2008-03-12 노보자임스 에이/에스 항균성을 가진 폴리펩티드 및 그것을 코딩하는폴리뉴클레오티드
US20080139450A1 (en) 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
US20070190110A1 (en) 2006-02-10 2007-08-16 Pameijer Cornelis H Agents and devices for providing blood clotting functions to wounds
KR101475447B1 (ko) 2006-12-01 2014-12-23 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 자기-조립 블록 코폴리머의 베시클 그리고 그것의 제조 및 사용 방법
JP2010531189A (ja) 2007-06-25 2010-09-24 リポペプチド・アクチエボラーグ 新しい医療用製品
US20090081249A1 (en) 2007-08-27 2009-03-26 Massachusetts Institute Of Technology Bi-Functional Polymer-Attached Inhibitors of Influenza Virus
US20110098344A1 (en) 2008-06-19 2011-04-28 Nippon Shinyaku Co., Ltd. Drug carrier
CN102256613B (zh) 2008-10-20 2014-09-10 莫伊莱麦屈克斯公司 用于治疗或者预防粘连的多肽
CA2750340C (en) 2009-01-23 2017-09-19 Kane Biotech Inc. Biofilm-removing antimicrobial compositions and uses thereof
GB0905451D0 (en) 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
DK2563916T3 (en) 2010-04-27 2015-10-05 Lysando Ag METHOD FOR REDUCING biofilms
EP2608800B1 (en) 2010-08-23 2017-01-18 The Regents of The University of California Compositions and uses of materials with high antimicrobial activity and low toxicity
CN103370087A (zh) * 2011-01-19 2013-10-23 目立康株式会社 隐形眼镜用液体制剂
US9781949B2 (en) 2011-03-31 2017-10-10 The University Of Massachusetts Antimicrobial delivery systems, methods of manufacture, and methods of use thereof
MX344635B (es) 2012-03-23 2017-01-04 Amicrobe Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con el tejido.
DE102014101663A1 (de) 2014-02-11 2015-08-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Synthetische artifizielle Peptide mit antimikrobieller Wirkung
EP3194422B1 (en) 2014-09-19 2020-04-29 Tensive Controls, Inc. Anti-microbial peptides
AU2015338969B2 (en) * 2014-10-30 2020-08-27 Biomet Manufacturing, Llc Methods of preventing surgical site infections
JP2016113373A (ja) * 2014-12-11 2016-06-23 エスポ化学株式会社 抗菌性、抗ウイルス性を有する水溶性組成物
CN110740744A (zh) 2017-04-06 2020-01-31 艾麦克罗比公司 性能和安全性增强的局部施用的抗微生物剂的组合物和应用
WO2019169324A1 (en) 2018-03-02 2019-09-06 January Therapeutics, Inc. Nanoparticle compositions

Similar Documents

Publication Publication Date Title
JP5154933B2 (ja) カチオン性消毒剤組成物および使用方法
JP2020513016A5 (cg-RX-API-DMAC7.html)
CN101048135B (zh) 酚类抗菌剂组合物和使用方法
ES2261223T3 (es) Composiciones oftalmicas que contienen antibioticos y aines.
JP5726774B2 (ja) ロテプレドノールエタボネートおよびトブラマイシンの局所眼科用懸濁液
KR20070101229A (ko) 방부 조성물 및 이의 사용 방법
JPH08510454A (ja) 抗感染症薬剤
JP7656643B2 (ja) 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
JP2025090864A5 (cg-RX-API-DMAC7.html)
US20200253944A1 (en) Topical semisolid composition containing an antimicrobial agent and pirfenidone for the treatment of chronic skin damage
JP2007536233A (ja) ポリカチオン抗菌薬による治療
US20170273935A1 (en) Cineole-containing composition for nasal application
JP7490570B2 (ja) 抗微生物有効性の増強及び毒性の減少を有する亜塩素酸ナトリウム組成物
JPH1160505A (ja) 防腐組成物
JP2020512971A (ja) インサイチュゲル形成医薬組成物および副鼻腔疾患のためのその使用
JP2011525499A (ja) 酢酸及び緩衝剤
ES2234164T3 (es) Formulaciones oftalmicas acuosas que comprenden quitosano.
JP2003002837A (ja) 水性外用剤組成物及び液体組成物の白濁防止方法
JP5535209B2 (ja) 抗菌組成物
US7288622B1 (en) Composition for treatment of burns and wounds
EP2251003A2 (en) Ophthalmic Compositions for the Re-epithelialization, Healing and Disinfection of the Eye Tissues
US20230149333A1 (en) Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections
CN118576537A (zh) 一种卡波姆妇科凝胶及其制备方法
JP2003522109A (ja) 亜塩素酸塩と過酸化水素とを含有する共同作用抗菌性皮膚科・眼科製剤
CA3169401A1 (en) Xanthan-based ophthalmic topical formulations with a reduced dosage regimen